Intriguingly, upon treatment with CLS on NCI-H1975 cells, CLS suppressed the cytokine-cytokine receptor interaction, PIK-Akt and MAPK signaling pathways, leading to growth inhibition of the tumor in vitro and in vivo. The gene discussed is AKT1; the disease is neoplasm.